Mini-HCVD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mini-HCVD, covering 2025-05-23 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]